Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell
US12139713B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 2024 |
| Grant date | Nov 12, 2024 |
| Priority date | — |
| Expiry date | Jan 9, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/531
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the target cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis. The target cell may be a cancer cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.